Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants

Alexopoulou A, Theodorou M, Dourakis SP, Karayiannis P, Sagkana E, Papanikolopoulos K, Archimandritis AJ (2006) Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations. J Viral Hepat 13(9):591–596

Allain J-P (2004) Occult hepatitis B virus infection. Transfus Clin Biol 1:18–25

Avellón A, Echevarría JM (2006) Frequency of hepatitis B virus “a” determinant variants in unselected Spanish chronic carriers. J Med Virol 78:24–36

Awerkiew S, Däumer M, Reiser M, Wend U, Pfister H, Kaiser R, Willems W, Gerlich W (2007) Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti HBc negative lymphoma patient. J Clin Virol 38(1):83–86

Bünung H, Trenkler G (1978) Nicht-parametrierbare methoden. Springer, Berlin

Carman WF (1997) The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4:S11–S20

Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckermann AJ, Thomas HC (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325–329

Couroucé-Pauty AM, Plançon A, Soulier JP (1983) Distribution of HbsAg subtypes in the world. Vox Sang 44:197–211

Echevarría JM, Avellón A, Magnius LO (2005) Molecular epidemiology of hepatitis B virus in Spain: identification of viral genotypes and prediction of antigenic subtypes by limited sequencing. J Med Virol 76:176–184

Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL (1999) Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30(5):1312–1317

Hsu HY, Chang MH, Ni YH, Chen HL (2004) Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53(10):1499–1503

Jeantet D, Chemin I, Mandrand B, Tran A, Zoulim F, Merle P, Trepo P, Kay A (2004) Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. J Med Virol 73:508–515

Kuhns MC, McNamara AL, Holzmayer V, Lou SC, Busch MP (2006) Frequency of diagnostically significant hepatitis B surface antigen mutations. Clin Chem 52(Suppl):A43

Louisirirotchanakul S, Kanoksinsombat C, O’Charoen R, Fongsatikul L, Puapairoj C, Lulitanond V, Appassakij H, Promwong C, Wasi C (2006) HBsAg diagnostic kits in the detection of hepatitis B virus mutation within “a” determinant. Viral Immunol Spring 19(1):108–114

Ly TD, Servant-Delmas A, Bagot S, Gonzalo S, Frey MP, Ebel A, Dussaix E, Laperche S, Roque-Alfonso AM (2006) Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms. J Clin Microbiol 44(7):2321–2326

Moerman B, Moons V, Sommer H, Schmitt Y, Stetter M (2004) Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg Assays. Clin Lab 50:159–162

Mizuochi T, Okada Y, Umemori K, Mizusawa S, Yamaguchi K (2006) Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H. J Virol Methods 136:254–256

Norder H, Couroucé AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius O (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309

Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde KH, Neuhaus P, Gerken G (1998) Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 27:254–263

Rodriguez-Frias F, Brti M, Jardi R, Vargas V, Quer J, Cotrina M, Martell M, Esteban R, Guardia J (1999) Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation. Liver 19:177–182

Saldanha J, Gerlich WH, Lelie N, Dawson P, Heermann KH (2001) Heath A and the WHO Collaborative Study Group (2001). An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 80:63–71

Schaefer S, Glebe D, Wend UC, Oyunbileg J, Gerlich WH (2003) Universal primers fort he real time amplification of DNA from all known orthohepadnavirus species. J Clin Virol 27:30–37

Torresi J (2002) The virological and clinical significance of mutations in the overlapping polymerase genes of hepatitis B virus. J Clin Virol 25:97–106

Weber B, Bayer A, Kirch P, Schlüter V, Schlieper D, Melchior W (1999) Improved detection of hepatitis B virus surface antigen by a new rapid automated assay. J Clin Microbiol 37:2639–2647

Weber B, Dengler T, Berger A, Doerr HW, Rabenau H (2003) Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg. J Clin Microbiol 41:135–143

Weber B (2005) Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 32:102–112

Weber B (2006) Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 78(Suppl 1):S59–S65

Weber B, Van der Taelem-Brule N, Berger A, Simon F, Geudin M, Ritter J (2006) Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra. J Virol Methods 135:109–117

Westhoff TH, Jochimsen F, Schmittel A, et al. (2003) Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 102:1930

Zanetti AR, Tanzi E, Manzillo G, Maio G, Sbreglia C, Caporaso N, Thomas H, Zuckerman AJ (1988) Hepatitis B variant in Europe. Lancet ii:1132–1133